United States Genomics Industry - investments driving $115B Growth by 2031 | Most Leading Companies - BGI Genomics, Color Genomics, Inc., Danaher Corporation, Eurofins Scientific, Myriad Genetics, Inc

DataM Intelligence unveils its latest report on the "Genomics Market Size 2025," offering an in-depth analysis of market trends, growth drivers, competitive landscape, and regional dynamics. The study covers market size in value and volume, CAGR forecasts, and emerging opportunities that can guide businesses in seizing growth potential and crafting winning strategies. Packed with data-driven insights on current developments and future trends, this report is essential for companies aiming to stay ahead in the competitive Market.

Illumina, Inc. launched the NovaSeq X Series, high-throughput sequencers capable of producing over 20,000 whole genomes per year, accelerating genomic research and clinical insights with faster, more powerful, and sustainable sequencing.

Duke University Health System launched OneDukeGen, a precision medicine study integrating genomic and clinical data, aiming to enroll 100,000+ patients to explore hereditary disease risks.

Get a Free Sample PDF Of This Report (Get Higher Priority for Corporate Email ID):- https://datamintelligence.com/download-sample/genomics-market?kb

Latest M&A Activity

Major M&A deals in H1 2025 include Merck's $10 billion acquisition of Verona Pharma and Novartis' $1.7 billion acquisition of Regulus Therapeutics, both strengthening genomics-driven drug discovery and therapeutic pipelines.

Alumis' acquisition of Acelyrin valued at $737 million expanded its late-stage pipeline with genomics-linked asset ESK-001 and other

List of Top Key Player:

Agilent Technologies, Bio-Rad Laboratories, Inc., BGI Genomics, Color Genomics, Inc., Danaher Corporation, Eurofins Scientific, F. Hoffmann-La Roche Ltd., GE Healthcare, Illumina, Inc., and Myriad Genetics, Inc., among others.

Investments & Innovations

Venture funding remains strong in AI-powered bioinformatics, next-generation sequencing companies, and clinical genomics platforms, with leaders focusing on multi-omics analysis and disease biomarker discovery.

Companies like Nucleus Genomics are launching affordable whole-genome sequencing services to democratize access to genomic data for personalized health management and research (2024-2025 ongoing).

Forecast Projection:

The Global Genomics Market is poised for significant growth between 2025 and 2032. In 2024, the market maintained a steady upward trajectory, and with strategic initiatives by leading players accelerating adoption, the market is expected to soar throughout the forecast period. Companies leveraging these trends are well-positioned to capture emerging opportunities and maximize revenue potential.

Market Intelligence Research Process:

The Genomics Market research report by DataM Intelligence combines primary and secondary data to deliver deep, actionable insights. It examines the full spectrum of factors shaping the industry, from government regulations and market conditions to competitive dynamics, historical trends, technological breakthroughs, upcoming innovations, and potential challenges. This comprehensive analysis not only highlights growth prospects but also identifies barriers, equipping businesses to navigate market volatility and capitalize on emerging opportunities.

Buy Now & Unlock 360° Market Intelligence: https://www.datamintelligence.com/buy-now-page?report=genomics-market

Key Segmentation:

Functional genomics to drive ~34.3% of global market growth

By Application And Technology: (Functional Genomics, Pathway Analysis, Biomarker Discovery, Epigenetics, Others)

By-Products and services: (Products, Services, Core Genomics Services, Biomarker Translation Services, Computational Services)

By End User: (Clinical Research, Academic & Government Institutes, Hospitals & Clinics, Pharmaceutical & Biotechnology Companies)

Global Growth Regional Analysis:

⇥ North America (U.S., Canada, Mexico)

⇥ Europe (U.K., Italy, Germany, Russia, France, Spain, The Netherlands and Rest of Europe)

⇥ Asia-Pacific (India, Japan, China, South Korea, Australia, Indonesia Rest of Asia Pacific)

⇥ South America (Colombia, Brazil, Argentina, Rest of South America)

⇥ Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of Middle East & Africa)

Benefits of the Report:

Chapter 1 - Market Overview: Kickstarts the report with a comprehensive snapshot of the Genomics Market, summarizing key segments by region, product type, and application. Highlights include market size, segment growth potential, and short- & long-term industry outlook.

Chapter 2 - Emerging Trends: Uncovers the game-changing trends and high-impact innovations shaping the future of the industry.

Chapter 3 - Competitive Landscape: Offers a deep dive into market competition, detailing revenue shares, strategic initiatives, and recent mergers & acquisitions.

Chapter 4 - Top Player Profiles: Features detailed company profiles, covering revenue, profit margins, product lines, and major milestones for leading market players.

Chapters 5 & 6 - Regional & Country Analysis: Breaks down revenue performance across global regions, providing insights on market sizes, opportunities, and growth prospects worldwide.

Chapter 7 - Segmentation Analysis: Explores market segmentation by type, revealing high-potential categories and guiding businesses towards lucrative areas.

Chapter 8 - Application Insights: Examines downstream markets and identifies promising sectors for expansion, showing how different applications are driving growth.

Chapter 9 - Supply Chain Mapping: Maps the entire industry supply chain, highlighting upstream and downstream activities for a holistic market perspective.

Chapter 10 - Key Takeaways: Concludes with critical insights and actionable strategies, equipping stakeholders to make informed decisions and stay ahead in the market.

Get Customization in the report as per your requirements: https://datamintelligence.com/customize/genomics-market?kb

FAQ's

Q1: What is the current size of the Genomics Market and its future potential?

A: The Genomics Market was valued at USD 27.9 billion in 2022 and is projected to surge to USD 115.4 billion by 2031

Q2: How fast is the Genomics Market expected to grow in the coming years?

A: The market is forecast to expand at a robust CAGR of 18.7% between 2025 and 2032, signaling strong global growth and investment potential.

Q3: Which regions are dominating the Genomics Market and which are fastest-growing?

A: North America held 38.2% of the market share

Product Launches & FDA Approvals

New product launches include proteomics and genomic data integration platforms, enhancing drug discovery pipelines and clinical trial patient stratification.

The FDA continues to approve first-in-class and breakthrough therapies guided by genomic insights; recent approvals focus heavily on oncology, rare diseases, and gene therapies (Q3 2025).

Request 2 Days Free Trials with DataM Subscription Services: https://www.datamintelligence.com/reports-subscription?kb

Power your decisions with real-time competitor tracking, strategic forecasts, and global investment insights all in one place.

Have a look at our Subscription Dashboard: https://www.youtube.com/watch?v=x5oEiqEqTWg

Contact Us -
Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com

About Us -

DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.

Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.

This release was published on openPR.